Companies: 10,795·Total market cap: $144.5T
STAAR Surgical Company

STAAR Surgical Company

STAANASDAQHealthcare● Active
$30.64
+$0.65(+2.17%)
Market Cap$1.5B
P/E Ratio
52W High$35.87
52W Low$15.59
Overview

STAAR Surgical Company (STAA) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · STAA · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.42staa eps ttm · staa earnings per shareEarnings history
PE Ratio (TTM)staa pe ratio ttm · staa price to earningsPE Ratio deep dive
Revenue (TTM)$290.4Mstaa revenue ttm · staa annual revenueFull revenue history
Dividend YieldNo Dividenddoes staa pay dividends · staa dividend yieldDividend history
Shares Outstanding49.6Mstaa shares outstanding · staa floatShares outstanding history
Next EarningsAug 12, 2026Est.staa earnings date · staa next earningsEarnings history

Financial Snapshot

Full Financials
FY 2026Revenue$239.4M▼ 23.72% YoY
202320242026
staar surgical company revenue · staa revenue 2026
FY 2026Net Income-$80.4M▼ 298.10% YoY
202320242026
staar surgical company net income · staa profit 2026
FY 2026EPS$-1.62▼ 295.12% YoY
202320242026
staa eps · staar surgical company earnings per share 2026
TTM:Revenue: $290.4MNet Income: -$21.0MEPS: $-0.42View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold15 analystsis staa a buy · staa analyst rating
Strong Buy
0
Buy
4
Hold
10
Sell
1
Strong Sell
0
12-Month Price Target
$13.00Low
$30.64Current
$29.54Avg Target3.59% downside
$40.00High
staa price target · staa 12 month forecast

Total: 15 · Buy rate: 26.7%

The STAA analyst consensus is Hold, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $29.54, representing -3.59% downside from the current price of $30.64.

Stock Performance

Full History
1D+2.10%
1W+6.39%
1M+14.72%
3M+65.87%
YTD+32.61%
1Y+78.33%
5Y-78.56%

About STAAR Surgical Company

CEOWarren Foust
IPO DateFeb 24, 1992
Employees1,157
CountryUS
Websitestaar.com

STAAR Surgical Company together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into th…

what is staar surgical company · staa stock overview · staar surgical company company profile · who is staar surgical company ceo · staa NASDAQ · staar surgical company headquarters · staar surgical company business segments

About Stock Overview & Key Data

STAAR Surgical Company (STAA) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Feb 24, 1992. As of the latest trading session, STAA stock price is $30.64, with a market capitalization of $1.5B. The stock has returned +78.33% over the past 12 months and +32.61% year-to-date.

According to 15 Wall Street analysts, the consensus rating for STAAR Surgical Company stock is Hold, with an average 12-month price target of $29.54. In fiscal year 2026, STAAR Surgical Company reported revenue of $239.4M and net income of -$80.4M. For detailed data — including STAAR Surgical Company revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, STAAR Surgical Company (STAA) stock price is $30.64. The stock is traded on NASDAQ under the ticker symbol STAA. The 52-week range is $15.59 – $35.87.

STAA stock priceSTAA quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice